GLP-3 (RT)

Retatrutide is an advanced next-generation triple agonist research peptide targeting GIP (Glucose-dependent Insulinotropic Polypeptide), GLP-1 (Glucagon-like Peptide-1), and Glucagon receptors. Engineered for superior metabolic signaling and weight management research.

Primary Functional Benefits & Research Applications

• Accelerated Weight Management & Fat Metabolism: Promotes multi-pathway caloric efficiency, lipolysis, and energy expenditure through glucagon receptor activation.
• Glycemic Control & Insulin Sensitivity: Enhances glucose-dependent insulin secretion while stabilizing plasma glucose dynamics.
• Appetite Regulation & Gastric Emptying Modulation: Acts on central satiety centers to reduce food intake and delay gastric motility.
• Lipid & Liver Health Optimization: Induces reduction in hepatic fat accumulation and improves overall metabolic biomarker profiles..

All orders ship with thermally monitored packaging to preserve product integrity in transit.

Store lyophilized vials between 2°C and 8°C for short-term handling, or frozen at -20°C for long-term preservation.